Otsuka Holdings Co (4578.T) Stock Price
Otsuka Holdings Co Price
Otsuka Holdings Co (4578.T) Stock | ISIN JP3188220002 | WKN A1C9KC. The current Otsuka Holdings Co stock price is 10,305 JPY (2026). Revenue is 2.49 T JPY. Net income is 289.7 B JPY. The P/E ratio is 19.26. Market capitalization is 5.58 T JPY. Otsuka Holdings Co operates in the Health sector.
Otsuka Holdings Co stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Otsuka Holdings Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Otsuka Holdings Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Otsuka Holdings Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Otsuka Holdings Co Price |
|---|
Otsuka Holdings Co Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Otsuka Holdings Co Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (M JPY) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M JPY) |
| NET INCOME (M JPY) |
| NET INCOME GROWTH (%) |
| DIVIDEND (JPY)DIV. (JPY) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Otsuka Holdings Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Otsuka Holdings Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Otsuka Holdings Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Otsuka Holdings Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Otsuka Holdings Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Otsuka Holdings Co stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Otsuka Holdings Co Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Otsuka Holdings Co business model & stock analysis
Otsuka Holdings Co SWOT Analysis
Strengths
Otsuka Holdings Co Ltd has maintained a strong financial performance, which allows it to invest in research and development, expand its product portfolio, and pursue growth opportunities.
With a diverse range of products in areas such as pharmaceuticals, nutraceuticals, and beverages, Otsuka Holdings Co Ltd is well-positioned in multiple markets. This diversification helps mitigate risks by reducing dependence on any single product or market.
Otsuka Holdings Co Ltd has a strong commitment to research and development, enabling it to innovate and bring new products to market. The company's R&D capabilities contribute to its ability to address unmet medical needs and maintain a competitive edge.
Weaknesses
Otsuka Holdings Co Ltd heavily relies on key markets for a significant portion of its revenue. Any adverse changes in these markets, such as regulatory hurdles or economic downturns, could have a negative impact on the company's financial performance.
While Otsuka Holdings Co Ltd has a strong presence in its home market, Japan, its global reach is relatively limited compared to some of its competitors. This could restrict its growth potential and make it vulnerable to fluctuations in regional markets.
As a company operating in the healthcare industry, Otsuka Holdings Co Ltd faces the inherent risk of product recalls. Any product quality issues or safety concerns could damage the company's reputation and financial performance.
Opportunities
Otsuka Holdings Co Ltd can capitalize on the growing demand for healthcare products and services in emerging markets. By expanding its operations and distribution networks in these markets, the company can tap into new sources of revenue and achieve long-term growth.
Advancements in technology, such as digital healthcare solutions and artificial intelligence, present opportunities for Otsuka Holdings Co Ltd to develop innovative products and improve patient care. Investing in these areas can enhance the company's competitive position.
Forming strategic partnerships and collaborations with other companies or research institutions can provide Otsuka Holdings Co Ltd with access to new technologies, expertise, and markets. Such collaborations can foster innovation and support the company's growth strategy.
Threats
The healthcare industry is highly competitive, with many players vying for market share. Otsuka Holdings Co Ltd faces competition from both domestic and international companies, which could impact its market position and profitability.
Regulatory requirements and compliance pose challenges to Otsuka Holdings Co Ltd, particularly in the pharmaceutical sector. Changes in regulations or failure to meet compliance standards could result in delays, increased costs, or even product restrictions.
Global economic uncertainties, market volatility, and currency fluctuations can affect Otsuka Holdings Co Ltd's financial performance and profitability, especially when it comes to operating in international markets.
Otsuka Holdings Co Eulerpool Fair Value
Otsuka Holdings Co historical P/E ratio, EBIT multiple, and P/S ratio
Otsuka Holdings Co annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Otsuka Holdings Co shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Otsuka Holdings Co Dividend History
15 years of dividend payments · 3 consecutive increases
Otsuka Holdings Co dividend history and estimates
Max
Details
Otsuka Holdings Co dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Otsuka Holdings Co Earnings Estimates
Otsuka Holdings Co Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 5/10/2024 | 102.52JPY | 480.45 BJPY | 2024 Q1 |
| 2/12/2024 | 85.12JPY | 510.25 BJPY | 2023 Q4 |
| 7/27/2023 | 51.4JPY | 507.2 BJPY | 2023 Q2 |
| 5/11/2023 | 51.93JPY | 434.32 BJPY | 2023 Q1 |
| 2/8/2023 | 28.41JPY | 438.35 BJPY | 2022 Q4 |
| 10/31/2022 | 74.31JPY | 448.27 BJPY | 2022 Q3 |
| 7/29/2022 | 82.1JPY | 416.99 BJPY | 2022 Q2 |
| 5/13/2022 | 68.99JPY | 371.11 BJPY | 2022 Q1 |
| 2/10/2022 | 32.19JPY | 391.48 BJPY | 2021 Q4 |
| 11/12/2021 | 92.47JPY | 389.02 BJPY | 2021 Q3 |
EESG©
Eulerpool ESG Scorecard© for the Otsuka Holdings Co stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Otsuka Holdings Co shareholder structure
| % | Name |
|---|---|
9.78059% | |
5.06037% | |
2.64258% | |
2.50352% | |
2.4076% | |
2.38826% | |
2.31522% | |
2.02623% | |
2.01295% | |
1.90731% |
Otsuka Holdings Co Executives and Management Board
Mr. Tatsuo Higuchi
(74)Chairman of Subsidiary, Director · since 2008
Mr. Ichiro Otsuka
(58)Chairman of the Board, Representative Director · since 2008
Mr. Yoshiro Matsuo
(62)Vice President, Representative Director · since 2008
Mr. Makoto Inoue
(65)President, Chief Executive Officer, President of Subsidiary, Representative Director · since 2020
Ms. Yuko Makino
(63)Chief Financial Officer, Director · since 2016
Otsuka Holdings Co Supply Chain
Frequently asked questions about Otsuka Holdings Co
The business model of Otsuka Holdings Co Ltd focuses on healthcare, pharmaceuticals, and nutraceuticals. As a leading global company, Otsuka Holdings creates and markets innovative products and solutions to improve the overall health and well-being of individuals worldwide. Their business strategy centers around research, development, and commercialization of pharmaceuticals and medical devices that target unmet medical needs. In addition, Otsuka Holdings also offers nutritional food products and beverages. By leveraging their expertise and commitment to innovation, Otsuka Holdings aims to contribute to the advancement of healthcare and ultimately improve the quality of life for people around the globe.
Otsuka Holdings Co stock
Otsuka Holdings Co Peer Group
Otsuka Holdings Co Ticker
Otsuka Holdings Co FIGI
All fundamentals and in-depth analysis of Otsuka Holdings Co
Our stock analysis for Otsuka Holdings Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Otsuka Holdings Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.